As of June 2026 Agomab Therapeutics has a market cap of NZ$0.82 Billion. This makes Agomab Therapeutics the world's 7342th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jun 9th, 2026 the market cap of Agomab Therapeutics was reported to be: